Liver transplantation in PBC and PSC: Indications and disease recurrence

被引:57
作者
Carbone, Marco [1 ]
Neuberger, James [1 ]
机构
[1] Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England
关键词
PRIMARY BILIARY-CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; INFLAMMATORY-BOWEL-DISEASE; POUCH-ANAL ANASTOMOSIS; URSODEOXYCHOLIC ACID TREATMENT; SINGLE-CENTER EXPERIENCE; LONG-TERM SURVIVAL; QUALITY-OF-LIFE; ULCERATIVE-COLITIS; RISK-FACTORS;
D O I
10.1016/j.clinre.2011.02.007
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) represent major indications for liver transplantation (LT). Despite the steady increase in the incidence and prevalence of PBC, the number of liver transplants for PBC has fallen in recent years, whereas the number of transplants for PSC has remained stable. Indications for LT for PBC and PSC are no different from those of other causes of chronic liver disease, apart from some disease-specific indications. PBC and PSC have more favourable outcomes after LT, compared to viral hepatitis and alcohol-associated liver disease. Numerous studies have clearly demonstrated that PBC and PSC recur after LT. The diagnosis of recurrent disease should be made on agreed criteria. The impact of recurrent disease on survival is unclear. Study of recurrent PBC and PSC may provide a better understanding of the mechanisms of these diseases in the native liver. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:446 / 454
页数:9
相关论文
共 129 条
[1]
Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests [J].
Abraham, Susan C. ;
Poterucha, John J. ;
Rosen, Charles B. ;
Demetris, Anthony J. ;
Krasinskas, Alyssa M. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2008, 32 (07) :965-973
[2]
Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy [J].
Abraham, Susan C. ;
Kamath, Patrick S. ;
Eghtesad, Bijan ;
Demetris, Anthony J. ;
Krasinskas, Alyssa M. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (11) :1454-1461
[3]
AbuElmagd K, 1997, HEPATOLOGY, V26, P190
[4]
Evolution of liver transplantation in Europe: Report of the European liver transplant registry [J].
Adam, P ;
McMaster, P ;
O'Grady, JG ;
Castaing, D ;
Klempnauer, JL ;
Jamieson, N ;
Neuhaus, P ;
Lerut, J ;
Salizzoni, M ;
Pollard, S ;
Muhlbacher, F ;
Rogiers, X ;
Valdecasas, JCG ;
Berenguer, J ;
Jaeck, D ;
Gonzalez, EM .
LIVER TRANSPLANTATION, 2003, 9 (12) :1231-1243
[5]
Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis [J].
Ahrendt, SA ;
Pitt, HA ;
Nakeeb, A ;
Klein, AS ;
Lillemoe, KD ;
Kalloo, AN ;
Cameron, JL .
JOURNAL OF GASTROINTESTINAL SURGERY, 1999, 3 (04) :357-367
[6]
A Re-Evaluation of the Risk Factors for the Recurrence of Primary Sclerosing Cholangitis in Liver Allografts [J].
Alabraba, Edward ;
Nightingale, Peter ;
Gunson, Bridget ;
Hubscher, Stefan ;
Olliff, Simon ;
Mirza, Darius ;
Neuberger, James .
LIVER TRANSPLANTATION, 2009, 15 (03) :330-340
[7]
Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation [J].
Alexander, Jacob ;
Lord, James D. ;
Yeh, Matthew M. ;
Cuevas, Carlos ;
Bakthavatsalam, Ramasamy ;
Kowdley, Kris V. .
LIVER TRANSPLANTATION, 2008, 14 (02) :245-251
[8]
Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy [J].
Babatin, M. A. ;
Sanai, F. M. ;
Swain, M. G. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (05) :813-820
[9]
Long-term outcome of human leukocyte antigen mismatching in liver transplantation: Results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database [J].
Balan, Vijayan ;
Ruppert, Kris ;
Demetris, A. Jake ;
Ledneva, Tatiana ;
Duquesnoy, Rene J. ;
Detre, Katherine M. ;
Wei, Yuling L. ;
Rakela, Jorge ;
Schafer, Daniel F. ;
Roberts, John P. ;
Everhart, James E. ;
Wiesner, Russell H. .
HEPATOLOGY, 2008, 48 (03) :878-888
[10]
Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients [J].
Battezzati, PM ;
Zuin, M ;
Crosignani, A ;
Allocca, M ;
Invernizzi, P ;
Selmi, C ;
Villa, E ;
Podda, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (09) :1427-1434